Regenerative Biologics for Wellness & Longevity Practices
Regenerative Biologics for Wellness & Longevity Practices: UCT-MSC Stem Cells & Exosomes for Functional Medicine
The regenerative biologic platform the longevity market has been waiting for.
Clinical-grade 25M UCT-MSC vials and 3D-cultured exosome biologics for wellness centers, longevity clinics, IV therapy practices, and functional medicine providers. Address the biology of aging at the cellular level — inflammaging, cellular senescence, immune dysregulation, and mitochondrial decline. USA-made, cGMP-aligned, FDA Type II Drug Master File registered.
Why Longevity & Wellness Practices Are Adding Regenerative Biologics
The longevity medicine market is shifting from symptom management to root-cause biology. Patients coming to functional medicine, IV therapy, and wellness clinics are increasingly sophisticated — they are asking about "inflammaging," cellular senescence, and systemic immune modulation. Peptides, NAD+, and IV nutrition are table stakes in this market now. UCT-MSC biologics are the next tier.
The scientific rationale is compelling: chronic low-grade inflammation — the "inflammaging" phenomenon — is now recognized as the central driver of accelerated biological aging. MSC-derived biologics address this directly through immunomodulatory paracrine signaling, not through pharmaceutical suppression.
Next Tier Beyond Peptides
Peptides and NAD+ are now standard longevity offerings. UCT-MSC biologics position your practice at the frontier — offering what elite biohacking and longevity clinics are adopting first.
Addresses Inflammaging Directly
MSC biologics target the chronic low-grade systemic inflammation driving accelerated biological aging — through macrophage polarization, NF-κB suppression, and Treg modulation.
High-Value Subscription Revenue
Wellness IV exosome protocols generate $795–$1,495 per session with subscription models driving $19,900–$31,800/month from 20–30 active members alone.
Stacks with Existing Protocols
UCT-MSC biologics integrate naturally alongside NAD+, peptides, glutathione, and other IV wellness protocols — expanding the session value without replacing what works.
The Biology of Aging — What UCT-MSC Biologics Address
Longevity medicine is converging on a small set of biological drivers that underlie most age-related decline. UCT-MSC biologics are relevant to several of them simultaneously — which is what makes them uniquely valuable in a functional medicine context.
Inflammaging & NF-κB Suppression
Chronic low-grade systemic inflammation — "inflammaging" — is driven by persistent NF-κB pathway activation and declining immune regulation. UCT-MSC exosomes carry microRNAs that suppress NF-κB expression and promote M1→M2 macrophage polarization, directly reducing the inflammatory burden driving accelerated aging.
Immune Regulation & Treg Support
Immune dysregulation — declining Treg populations and rising Th17 activity — is a hallmark of aging. MSC-derived exosomes increase regulatory T-cell populations and their products, helping restore the immune balance that deteriorates with age and drives both autoimmune tendencies and chronic inflammation.
Paracrine Repair Activation
MSCs secrete cytokines, signaling molecules, and growth factors that activate endogenous stem cells to perform tissue repair after damage (Gnecchi et al., 2016). This paracrine mechanism — signaling the body's own repair machinery — is the primary reason UCT-MSC biologics are relevant to systemic wellness and longevity protocols.
MicroRNA Gene Expression Recalibration
UCT-MSC exosomes contain over 800 unique microRNAs that influence gene expression across multiple biological pathways simultaneously. MSC-derived EVs play obvious therapeutic roles in diseases of tissue damage or inflammation, with broad implications for aging-related biological decline (Wei et al., Frontiers in Pharmacology, 2021).
The Stem Nova Wellness & Longevity Product Stack
Three biologics — a live MSC vial for systemic cellular protocols, a 3D-cultured exosome matrix for IV and adjunct wellness applications, and a topical serum for aesthetic skin aging support.
25M UCT-MSC Vial
The highest-tier biologic for systemic longevity and cellular renewal protocols. Live human umbilical cord tissue-derived MSCs from a perinatal source — biologically young, never lyophilized, with verified viability and purity on every lot. The primary product for practices offering premium UCT-MSC protocols.
3DExo+™ Matrix with Growth Factor
The cell-free exosome biologic for IV wellness and adjunct longevity protocols. Consistent, NTA-verified payload of extracellular vesicles, growth factors, and microRNAs — stackable with NAD+, glutathione, peptides, and other IV drip components at practitioner discretion.
3DExo+™ Topical Serum
A retail upsell product for longevity and wellness patients who want at-home biologic support between clinic visits. 12 billion EVs in a lightweight 10mL cosmetic-grade serum — anti-aging skin support as a natural complement to systemic protocols.
Suggested Retail Pricing — Wellness IV Subscription Model
The highest-volume revenue driver in the Stem Nova subscription model is the Wellness IV tier — 30 of 50 members in the revenue scenario are on Wellness IV plans. Below are suggested retail pricing tiers.
60B Exosome Wellness IV
25M UCT-MSC Stem Cell
Revenue Model (50 Members)
How UCT-MSC Biologics Stack with Your Current Protocols
One of the most common questions from wellness and longevity practices is how to position exosome biologics alongside existing offerings. The answer is as a next-tier upsell — not a replacement. Here are the most common integration patterns:
Exosome IV Upgrade
Add the 3DExo+™ 60B as a premium IV add-on or standalone drip. Positions above NAD+, glutathione, and Myers' cocktail in a premium tier with significantly higher session value.
Systemic Inflammation Protocol
25M UCT-MSC as a quarterly systemic immunomodulation protocol for patients with chronic inflammatory burden, autoimmune tendencies, or accelerated biological aging markers.
Longevity Stack
UCT-MSC biologics alongside peptide protocols (BPC-157, TB-500, Epithalon, MOTS-C), NAD+, and hormone optimization — addressing cellular aging through multiple complementary pathways.
Premium Membership Add-On
Quarterly or semi-annual UCT-MSC sessions as a premium tier in concierge or direct primary care membership models — adding significant revenue per patient at high perceived value.
How Enrollment Works
Submit Your Enrollment
Complete the clinic enrollment form at stemnovanetwork.com/apps/wpdapp. Takes less than 5 minutes. Proof of licensure required. Wellness centers, IV therapy clinics, functional medicine practices, longevity clinics, and concierge medicine providers are all eligible.
Get Approved & Access Wholesale Pricing
Most practices are approved within 1 business day. Once approved you unlock wholesale pricing, lot-specific COAs, NTA verification data, and direct access to our clinical support team.
Place Your Order & Start Your Protocol
MSC vials ship overnight on dry ice in cryogenic packaging. Exosome vials are shelf-stable. Most practices receive their first order within 2–3 business days of approval.
Frequently Asked Questions for Wellness & Longevity Practices
How do UCT-MSC biologics differ from the peptides and NAD+ we already offer?
Peptides and NAD+ work through specific, targeted pathways — BPC-157 for tissue repair signaling, NAD+ for mitochondrial function and sirtuin activation. UCT-MSC biologics work systemically through immunomodulation and paracrine signaling — they influence the inflammatory and repair environment across multiple systems simultaneously, rather than targeting a single pathway. They are complementary, not competitive. Most longevity practices position UCT-MSC biologics as the premium tier above peptides and IV nutrition.
What is "inflammaging" and how do UCT-MSC biologics address it?
Inflammaging is the term for the chronic, low-grade systemic inflammation that accumulates with aging and drives most age-related disease — cardiovascular disease, neurodegeneration, metabolic dysfunction, and immune decline. It is driven by persistent NF-κB activation, declining Treg populations, and rising M1 macrophage activity. UCT-MSC exosomes carry microRNAs that suppress NF-κB expression, promote M1→M2 macrophage polarization, and support Treg expansion — directly addressing the core biological mechanisms of inflammaging.
Can these biologics be used alongside peptide protocols like BPC-157, TB-500, or Epithalon?
Protocol design combining biologics with peptides or other wellness interventions is entirely at the discretion of the licensed practitioner. From a mechanistic standpoint, UCT-MSC biologics and peptides operate through largely distinct pathways, which is why they are frequently positioned as complementary tiers. All protocol decisions must comply with applicable federal and state regulations.
What is the difference between the 3DExo+™ 60B and the 25M UCT-MSC vial for wellness protocols?
The 3DExo+™ is cell-free — it delivers extracellular vesicles and their signaling cargo without live cells. It requires no cryogenic storage, has a simpler handling workflow, and is positioned as the IV wellness and adjunct tier. The 25M UCT-MSC vial contains live cells that actively secrete paracrine factors in the target tissue environment — it is the higher-tier, more potent systemic option for practices offering premium quarterly or semi-annual cellular longevity protocols. Both are clinically relevant; the choice depends on the protocol tier and patient profile at practitioner discretion.
Are Stem Nova biologics FDA approved for longevity or anti-aging use?
No. Stem Nova Network biologics are not FDA-approved drugs or therapeutic agents and are not indicated for anti-aging, longevity, or any specific condition. They are supplied as research-grade biologics for licensed professional use only. Practitioners are responsible for compliance with all applicable federal and state regulations. Stem Nova maintains an FDA Type II Drug Master File documenting manufacturing transparency.
What documentation is included with every order?
Every order includes a lot-specific Certificate of Analysis confirming: cell count and viability (97% specification for MSC vials), flow cytometry CD panel (CD90, CD166, CD34, CD45), sterility, endotoxin, mycoplasma, NTA particle count (Zetaview), and total protein concentration. FDA Type II Drug Master File documentation available upon request.
Related Resources
- How to Add Exosome Therapy to Your Clinic in 2026
- Are Exosomes FDA Approved? What Clinics Need to Know
- 3D Exosomes vs. PRP — What Clinics Need to Know
- Exosome Biologics for Medspas — Wholesale Supplier Guide
- Regenerative Biologics for Orthopedic & Pain Management Practices
- Exosome Biologics for Hair Restoration Practices
- Quality & Testing Standards: NTA Reports, COAs, and cGMP Compliance
- Browse the Full Stem Nova Biologics Catalog
Ready to Add Regenerative Biologics to Your Wellness Practice?
Wholesale pricing, lot-specific COAs, and clinical support — available to licensed professionals upon credential verification. Most practices approved within 24 hours.